3 weeks MCK Stock Down on Q3 Earnings & Sales Miss, Gross Margin Contracts Zacks

McKesson’s third-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.